vs

Side-by-side financial comparison of ENVIRI Corp (NVRI) and DENTSPLY SIRONA Inc. (XRAY). Click either name above to swap in a different company.

DENTSPLY SIRONA Inc. is the larger business by last-quarter revenue ($961.0M vs $555.0M, roughly 1.7× ENVIRI Corp). ENVIRI Corp runs the higher net margin — -15.2% vs -15.2%, a 0.0% gap on every dollar of revenue. On growth, DENTSPLY SIRONA Inc. posted the faster year-over-year revenue change (6.2% vs -0.8%). DENTSPLY SIRONA Inc. produced more free cash flow last quarter ($60.0M vs $-10.5M). Over the past eight quarters, DENTSPLY SIRONA Inc.'s revenue compounded faster (0.4% CAGR vs -3.8%).

Enviri Corporation is an environmental company based in Philadelphia, Pennsylvania. It operates in over 30 countries and employs approximately 12,000 people worldwide. The company addresses complex environmental issues for large industries, including steel, railways, and energy.

Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million.

NVRI vs XRAY — Head-to-Head

Bigger by revenue
XRAY
XRAY
1.7× larger
XRAY
$961.0M
$555.0M
NVRI
Growing faster (revenue YoY)
XRAY
XRAY
+6.9% gap
XRAY
6.2%
-0.8%
NVRI
Higher net margin
NVRI
NVRI
0.0% more per $
NVRI
-15.2%
-15.2%
XRAY
More free cash flow
XRAY
XRAY
$70.5M more FCF
XRAY
$60.0M
$-10.5M
NVRI
Faster 2-yr revenue CAGR
XRAY
XRAY
Annualised
XRAY
0.4%
-3.8%
NVRI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NVRI
NVRI
XRAY
XRAY
Revenue
$555.0M
$961.0M
Net Profit
$-84.3M
$-146.0M
Gross Margin
46.1%
Operating Margin
-6.4%
-14.5%
Net Margin
-15.2%
-15.2%
Revenue YoY
-0.8%
6.2%
Net Profit YoY
0.7%
66.0%
EPS (diluted)
$-1.04
$-0.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NVRI
NVRI
XRAY
XRAY
Q4 25
$555.0M
$961.0M
Q3 25
$574.8M
$904.0M
Q2 25
$562.3M
$936.0M
Q1 25
$548.3M
$879.0M
Q4 24
$559.2M
$905.0M
Q3 24
$573.6M
$951.0M
Q2 24
$610.0M
$984.0M
Q1 24
$600.3M
$953.0M
Net Profit
NVRI
NVRI
XRAY
XRAY
Q4 25
$-84.3M
$-146.0M
Q3 25
$-22.3M
$-427.0M
Q2 25
$-47.6M
$-45.0M
Q1 25
$-13.4M
$20.0M
Q4 24
$-84.9M
$-430.0M
Q3 24
$-13.2M
$-494.0M
Q2 24
$-13.6M
$-4.0M
Q1 24
$-18.0M
$18.0M
Gross Margin
NVRI
NVRI
XRAY
XRAY
Q4 25
46.1%
Q3 25
48.8%
Q2 25
52.4%
Q1 25
53.0%
Q4 24
49.3%
Q3 24
52.1%
Q2 24
51.9%
Q1 24
53.1%
Operating Margin
NVRI
NVRI
XRAY
XRAY
Q4 25
-6.4%
-14.5%
Q3 25
2.9%
-24.1%
Q2 25
-1.3%
-13.7%
Q1 25
5.6%
7.2%
Q4 24
-11.4%
-56.2%
Q3 24
6.5%
-48.6%
Q2 24
5.1%
5.1%
Q1 24
4.3%
4.4%
Net Margin
NVRI
NVRI
XRAY
XRAY
Q4 25
-15.2%
-15.2%
Q3 25
-3.9%
-47.2%
Q2 25
-8.5%
-4.8%
Q1 25
-2.4%
2.3%
Q4 24
-15.2%
-47.5%
Q3 24
-2.3%
-51.9%
Q2 24
-2.2%
-0.4%
Q1 24
-3.0%
1.9%
EPS (diluted)
NVRI
NVRI
XRAY
XRAY
Q4 25
$-1.04
$-0.74
Q3 25
$-0.28
$-2.14
Q2 25
$-0.59
$-0.22
Q1 25
$-0.17
$0.10
Q4 24
$-1.07
$-2.09
Q3 24
$-0.16
$-2.46
Q2 24
$-0.17
$-0.02
Q1 24
$-0.22
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NVRI
NVRI
XRAY
XRAY
Cash + ST InvestmentsLiquidity on hand
$103.7M
$326.0M
Total DebtLower is stronger
$1.6B
$2.3B
Stockholders' EquityBook value
$255.1M
$1.3B
Total Assets
$2.7B
$5.4B
Debt / EquityLower = less leverage
6.10×
1.70×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NVRI
NVRI
XRAY
XRAY
Q4 25
$103.7M
$326.0M
Q3 25
$115.4M
$363.0M
Q2 25
$97.8M
$359.0M
Q1 25
$102.5M
$398.0M
Q4 24
$88.4M
$272.0M
Q3 24
$110.2M
$296.0M
Q2 24
$104.0M
$279.0M
Q1 24
$103.9M
$291.0M
Total Debt
NVRI
NVRI
XRAY
XRAY
Q4 25
$1.6B
$2.3B
Q3 25
Q2 25
Q1 25
Q4 24
$1.4B
$1.7B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
NVRI
NVRI
XRAY
XRAY
Q4 25
$255.1M
$1.3B
Q3 25
$361.1M
$1.5B
Q2 25
$376.3M
$2.0B
Q1 25
$409.0M
$2.0B
Q4 24
$391.5M
$1.9B
Q3 24
$484.0M
$2.5B
Q2 24
$485.7M
$3.1B
Q1 24
$500.9M
$3.3B
Total Assets
NVRI
NVRI
XRAY
XRAY
Q4 25
$2.7B
$5.4B
Q3 25
$2.8B
$5.7B
Q2 25
$2.8B
$6.1B
Q1 25
$2.7B
$6.0B
Q4 24
$2.6B
$5.8B
Q3 24
$2.8B
$6.6B
Q2 24
$2.8B
$6.9B
Q1 24
$2.8B
$7.1B
Debt / Equity
NVRI
NVRI
XRAY
XRAY
Q4 25
6.10×
1.70×
Q3 25
Q2 25
Q1 25
Q4 24
3.66×
0.90×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NVRI
NVRI
XRAY
XRAY
Operating Cash FlowLast quarter
$38.4M
$101.0M
Free Cash FlowOCF − Capex
$-10.5M
$60.0M
FCF MarginFCF / Revenue
-1.9%
6.2%
Capex IntensityCapex / Revenue
8.8%
4.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-39.9M
$104.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NVRI
NVRI
XRAY
XRAY
Q4 25
$38.4M
$101.0M
Q3 25
$34.4M
$79.0M
Q2 25
$22.0M
$48.0M
Q1 25
$6.6M
$7.0M
Q4 24
$36.3M
$87.0M
Q3 24
$1.4M
$141.0M
Q2 24
$39.0M
$208.0M
Q1 24
$1.3M
$25.0M
Free Cash Flow
NVRI
NVRI
XRAY
XRAY
Q4 25
$-10.5M
$60.0M
Q3 25
$2.7M
$40.0M
Q2 25
$-17.1M
$16.0M
Q1 25
$-15.0M
$-12.0M
Q4 24
$1.8M
$36.0M
Q3 24
$-40.2M
$98.0M
Q2 24
$5.4M
$156.0M
Q1 24
$-25.5M
$-9.0M
FCF Margin
NVRI
NVRI
XRAY
XRAY
Q4 25
-1.9%
6.2%
Q3 25
0.5%
4.4%
Q2 25
-3.0%
1.7%
Q1 25
-2.7%
-1.4%
Q4 24
0.3%
4.0%
Q3 24
-7.0%
10.3%
Q2 24
0.9%
15.9%
Q1 24
-4.3%
-0.9%
Capex Intensity
NVRI
NVRI
XRAY
XRAY
Q4 25
8.8%
4.3%
Q3 25
5.5%
4.3%
Q2 25
6.9%
3.4%
Q1 25
3.9%
2.2%
Q4 24
6.2%
5.6%
Q3 24
7.2%
4.5%
Q2 24
5.5%
5.3%
Q1 24
4.5%
3.6%
Cash Conversion
NVRI
NVRI
XRAY
XRAY
Q4 25
Q3 25
Q2 25
Q1 25
0.35×
Q4 24
Q3 24
Q2 24
Q1 24
1.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NVRI
NVRI

Products And Services Service Revenue$500.2M90%
After Market Parts And Services Safety And Diagnostic Technology$23.0M4%
Railway Track Maintenance Equipment$16.6M3%
Railway Contracting Services$15.9M3%
Aluminum Dross And Scrap Processing Systems$3.1M1%

XRAY
XRAY

Essential Dental Solutions$372.0M39%
Equipment And Instruments$160.0M17%
Implants And Prosthetics$150.0M16%
CADCAM$139.0M14%
Wellspect Healthcare$88.0M9%
Orthodontics$52.0M5%

Related Comparisons